Main Article Content
A Clinical Evaluation of COVID-19’s Third Wave Symptoms Severity on Patients in Zomba City: A Case Study of University of Malawi Clinic
Abstract
The impact of COVID-19 infections has been felt in Malawi since April 2020. Malawi readily benefited from the Coronavirus vaccine distribution program. While reagents were accessible for easy diagnosis, screening protocols kept changing. This paper assessed severity of symptoms among Coronavirus infected people as impacted by several factors in Zomba city. A cross-sectional study (n= 570) was conducted among patients accessing the University of Malawi COVID-19 clinic. Sex, age, disease outcome, vaccination status and underlying conditions data were collected. Log-linear multiple regression model was used for data analysis in R statistical analytical tool (Version 3.1). From July 2021 to October 2021, the clinic reported 179 (34.5%) third wave COVID-19 cases with a slightly higher males’ representation (54.8%) than females (45.2%). Significant variation of infection prevalence was represented by 71.1% and 3.2% in age groups 18-29 and 1-17 respectively (χ2 = 328.34, df = 4, p <.01). Majority of the infections were mild (90%) with few severe (5.1%) and asymptomatic (4.6%) cases (χ2 = 288.25, df = 2, p <.01). Underlying conditions (5.6%, n=197) were present among few infected individuals. Infection significantly varied according to vaccination status categories (χ2 = 284.63, df = 2, p <.01) with most of the un-immunized patients (89.8%), vaccinated with one dose (8.6%) and two doses (1.5%). A negative association of disease severity with underlying conditions [0.1(R: -0.4, p=.02)] and vaccination status (R: -0.4, p=.01) were observed. Coronavirus symptoms severity was positively associated with a vaccination status and age interaction (R: 0.01, p=0.01). Underlying conditions in consideration of age negatively determined severity (R: - 0.01, p=0.02). Further underlying conditions effect on severity assessment is needed to understand the relationship. Adherence to COVID-19 preventive and control measures i.e. vaccination, social distance and use of face masks reduce cases.